Latest Development Pipeline News

Elevra Lithium has completed a transformative merger and maintained robust production at its North American Lithium operation, while unveiling a compelling expansion plan that could boost output by 55% and slash costs.

Cedar Woods Properties has raised its FY26 net profit guidance to 15% growth, driven by a surge in presales hitting a record $763 million. The company’s strong pipeline and strategic acquisitions position it well amid a tight housing market.

Sunshine Metals reports significant progress in North Queensland with standout gold intersections at Sybil and a $5 million placement led by Lion Selection. Board reshuffle aligns leadership with growth strategy.

Desane Group Holdings has refinanced its corporate debt from Commonwealth Bank to National Australia Bank, increasing funding capacity to $18.8 million and securing improved terms to support its upcoming Penrith industrial development.

Bega Cheese Limited reported robust FY2025 results marked by strategic site consolidations, innovation-led growth, and a strong financial position, setting the stage for an optimistic FY2026.

Karoon Energy reported a 12% production dip in Q3 2025 due to operational challenges but saw a 3% revenue increase driven by higher oil prices and secured a new deepwater block in Brazil.

National Storage REIT delivered robust FY25 results, surpassing earnings guidance and expanding its development pipeline, while advancing sustainability and technology initiatives.

Mirvac Group reported a strong start to FY26 with a 79% surge in residential lot sales and a strategic joint venture with Mitsubishi Estate unlocking $450 million in capital. The company reaffirmed its full-year earnings guidance amid robust leasing and development progress.

Noxopharm Limited has been granted its first US patent for the Sofra™ technology platform, marking a key milestone in its cancer immunotherapy research. This patent protects the company’s innovative immune-modulatory oligonucleotides, underpinning its expanding pipeline in a rapidly growing market.

Imagion Biosystems has made significant strides toward filing an IND application for its MagSense® HER2 breast cancer imaging agent, supported by positive FDA feedback and a recent $3.5 million capital raise to fund upcoming clinical trials.

Horizon Minerals reported steady gold production from Boorara and Phillips Find, unveiled promising high-grade drilling results at Burbanks, and acquired the Gordons Project near Black Swan, while progressing a key Pre-Feasibility Study for a gold processing plant conversion.

Vectus Biosystems has requested an immediate suspension of its ASX-listed shares pending a significant announcement about a transaction involving a compound in its drug library.